![](/img/cover-not-exists.png)
Real-Options Valuation for a Biotechnology Company
David Kellogg and John M. CharnesVolume:
56
Language:
english
Journal:
Financial Analysts Journal
DOI:
10.2307/4480249
Date:
May, 2000
File:
PDF, 1.33 MB
english, 2000